Benobio Co., Ltd.
🇰🇷South Korea
Safety of BBC1501 Intravitreal Injection in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
- First Posted Date
- 2023-04-07
- Last Posted Date
- 2024-06-17
- Lead Sponsor
- Benobio Co., Ltd.
- Target Recruit Count
- 18
- Registration Number
- NCT05803785
- Locations
- 🇦🇺
Benobio Investigational site, Sydney, New South Wales, Australia
© Copyright 2025. All Rights Reserved by MedPath